{"name":"ProgenaBiome","slug":"progenabiome","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Fecal Microbial Transplantation","genericName":"Fecal Microbial Transplantation","slug":"fecal-microbial-transplantation","indication":"Clostridioides difficile infection (recurrent or refractory)","status":"phase_3"}]}],"pipeline":[{"name":"Fecal Microbial Transplantation","genericName":"Fecal Microbial Transplantation","slug":"fecal-microbial-transplantation","phase":"phase_3","mechanism":"Fecal microbial transplantation (FMT) restores a healthy gut microbiome by transferring bacterial communities from a healthy donor to a patient with dysbiosis.","indications":["Clostridioides difficile infection (recurrent or refractory)","Inflammatory bowel disease (Crohn's disease, ulcerative colitis)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxNYzRkUWlwTnNzZWkwMUYzbFlRNTNib0IxaElKVGRvblhGR3lNRjVfUjhxeEhrQzZ2UnlCUzBXd0Q2QVdQN21sVWFheXNJeGR0UmlrM3RBSzJFRUdoWEZXekJrNnFkNFNGcmI3cnVuTjh4MDJBN3Q4ZGFqV2wtS283cTlSX1dWYzdqeEVjd1JYRmEzaXVVN3JNeTltd01jSlZYeWZtMDNmUzhYcEtMZWRrLUh6dm1NRjNuSFo4TEVEY3BVQUl5cHpMRXdWcjh0dFU5?oc=5","date":"2023-12-07","type":"pipeline","source":"PR Newswire","summary":"ProgenaBiome Given Presidential Award at ACG Conference for Microbiome Research - PR Newswire","headline":"ProgenaBiome Given Presidential Award at ACG Conference for Microbiome Research","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxPalJyOEZLS2dSS1dSWW9fbjhmbDM0WWh5Y2J4cFNKeEpRck90bUhSdWVCclpZNWtWRzFwbEVhai16dGZJQUhIbV9JTE4yTzZCWWtfaENJaGlfVy14UTAwc2lmeEtQcUVaT0p2VVd6aEVWN1VtNjVPZEZFMUlwY0wyUmNzdDhHUE14emVmM0N3R3gyYjg0UUpERFlLX1I2c2tIRGZIQUFjS2FUMHJnVUdTUmc1OUJrTEs2dTV1VUtB?oc=5","date":"2022-10-24","type":"pipeline","source":"Pharmacy Times","summary":"Bacterium in the Gut Could be a Biomarker to Predict the Severity of COVID-19 Symptoms - Pharmacy Times","headline":"Bacterium in the Gut Could be a Biomarker to Predict the Severity of COVID-19 Symptoms","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}